Published in Women's Health Weekly, November 17th, 1997
The Novo Nordisk product is a combination of 17-beta estradiol, a plant-derived estrogen, and norethindrone acetate in a single tablet. The product was submitted for European approval in September 1997.
Novo Nordisk was the first company to introduce continuous combined HRT with another product, KliogestR, which is available in Europe, Asia, Australia, and other parts of the world.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly